[go: up one dir, main page]

NO991233L - Nye trisykliske piperidinylforbindelser anvendelige som inhibitorer av farnesylproteintransferase - Google Patents

Nye trisykliske piperidinylforbindelser anvendelige som inhibitorer av farnesylproteintransferase

Info

Publication number
NO991233L
NO991233L NO991233A NO991233A NO991233L NO 991233 L NO991233 L NO 991233L NO 991233 A NO991233 A NO 991233A NO 991233 A NO991233 A NO 991233A NO 991233 L NO991233 L NO 991233L
Authority
NO
Norway
Prior art keywords
inhibitors
protein transferase
farnesyl protein
compounds useful
cells
Prior art date
Application number
NO991233A
Other languages
English (en)
Other versions
NO991233D0 (no
Inventor
Alan B Cooler
Alan K Mallams
Viyyoor M Girijavallabhan
Ronald J Doll
Arthur G Taveras
F George Njoroge
John J Baldwin
John C Reader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO991233D0 publication Critical patent/NO991233D0/no
Publication of NO991233L publication Critical patent/NO991233L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Nye trisykliske forbindelser med formel (1.0) eller et farmasøytisk akseptabelt salt eller en oppløsning derav, hvori: en av a, b, c og d betegner N eller NR9, hvori R9 er O", CH3 eller (CH2)nCO2H, hvori n er 1-3, og de resterende a-, b-, c- og d-grupper betegner CR1 eller CR2; eller a, b, c og d er uavhengig av hverandre utvalgt fra CR1 eller CR2; R1 og R2 er uavhengig av hverandre ut- valgt fra H, halogen, CF3, OR 10 CO- R 10 SR 10 , S(0)tRi:L (hvori t er O, l 10 eller 2), SCN, N(R^) 2, NR OC(0)R10, C02R10, OC02R11 (0)R10, NHS02R10 ¿"«"10 'R11, N02, CN, NHC- CONHRiu, CONHCH2- CH2OH, NR10COOR11, SR1XC(O)OR1l, SR11N(R75)2; n er O, l, 2, 3, 4, 5 eller 6; T er CO, SO, S02, eller CR30- R31; Z betegner alkyl, aryl, aralkyl, heteroalkyl, heteroaryl, heteroaryl- alkyl, heterosykloalkyl, heterosyklo- alkylalkyl, OR40, SR40, CR40R42, NR40R42, formlene (i), (ii), (iii), (iv), (v) og (vi) (III) (v) Farmasøytiske preparater som er inhibi- torer av enzymet farnesylproteintrans- ferase er også beskrevet. En fremgangs- måte for inhibering av ras-funksjon og derved inhibering av den unormale vekst av celler er også beskrevet. Metoden omfatter administrering av den nye tri- sykliske forbindelse til et biologisk system. Nærmere bestemt inhiberer metoden den unormale vekst av celler i et pattedyr, slik som et menneske.
NO991233A 1996-09-13 1999-03-12 Nye trisykliske piperidinylforbindelser anvendelige som inhibitorer av farnesylproteintransferase NO991233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71370396A 1996-09-13 1996-09-13
PCT/US1997/015903 WO1998011098A1 (en) 1996-09-13 1997-09-11 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase

Publications (2)

Publication Number Publication Date
NO991233D0 NO991233D0 (no) 1999-03-12
NO991233L true NO991233L (no) 1999-05-12

Family

ID=24867181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991233A NO991233L (no) 1996-09-13 1999-03-12 Nye trisykliske piperidinylforbindelser anvendelige som inhibitorer av farnesylproteintransferase

Country Status (19)

Country Link
EP (1) EP0931078B1 (no)
JP (1) JP2001500507A (no)
KR (1) KR20000036104A (no)
CN (1) CN1237170A (no)
AT (1) ATE345338T1 (no)
AU (1) AU4337697A (no)
BR (1) BR9712826A (no)
CA (1) CA2265763A1 (no)
CZ (1) CZ84199A3 (no)
DE (1) DE69736950T2 (no)
ES (1) ES2276435T3 (no)
HU (1) HUP0000191A2 (no)
ID (1) ID21218A (no)
NO (1) NO991233L (no)
NZ (1) NZ334452A (no)
PL (1) PL332241A1 (no)
SK (1) SK33099A3 (no)
TR (1) TR199901274T2 (no)
WO (1) WO1998011098A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049700B9 (en) 1998-01-21 2006-05-10 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2335699A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
WO2002056884A2 (en) * 2001-01-22 2002-07-25 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
AU2002257114A1 (en) * 2001-04-06 2002-10-21 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2006012226A2 (en) * 2004-06-24 2006-02-02 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
MX2009003313A (es) * 2006-10-06 2009-04-09 Bausch & Lomb Acidos quinolona carboxilicos, derivados de los mismos, procesos para su preparacion y su uso como agentes antibacterianos.
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US20110136790A1 (en) * 2008-07-23 2011-06-09 De Lera Ruiz Manuel Tricyclic Heterocyclic Derivatives and Methods of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
NZ238629A (en) * 1990-06-22 1993-09-27 Schering Corp Bis-benzo- or benzopyrido-cyclohepta (where z is c, o, s or n) piperidine, piperidylidene or piperazine compounds, medicaments and methods of preparation
HUT76066A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases, pharmaceutical compositions containing them and process for producing them
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them

Also Published As

Publication number Publication date
CA2265763A1 (en) 1998-03-19
SK33099A3 (en) 2000-05-16
DE69736950T2 (de) 2007-09-20
CZ84199A3 (cs) 1999-11-17
ID21218A (id) 1999-05-06
AU4337697A (en) 1998-04-02
EP0931078A1 (en) 1999-07-28
ES2276435T3 (es) 2007-06-16
KR20000036104A (ko) 2000-06-26
HUP0000191A2 (hu) 2001-04-28
DE69736950D1 (de) 2006-12-28
WO1998011098A1 (en) 1998-03-19
TR199901274T2 (xx) 1999-10-21
JP2001500507A (ja) 2001-01-16
EP0931078B1 (en) 2006-11-15
BR9712826A (pt) 1999-11-16
ATE345338T1 (de) 2006-12-15
CN1237170A (zh) 1999-12-01
NO991233D0 (no) 1999-03-12
NZ334452A (en) 2000-09-29
PL332241A1 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
NO991233L (no) Nye trisykliske piperidinylforbindelser anvendelige som inhibitorer av farnesylproteintransferase
ATE242231T1 (de) Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase
DE69332860D1 (de) Bicyklische fibrinogen antagoniste
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT83961A (de) Pyrazolin-derivate ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung
DK0385237T3 (da) 2-(1-Piperazinyl)-4-phenylcycloalkanopyridinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende dem
NO941611D0 (no) Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser
RU94031155A (ru) Амидин - производные, способ их получения, их использование в качестве ингибиторов no - синтазы, фармсостав, способ лечения
ATE33838T1 (de) Thiazolidinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MX9803954A (es) Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos.
ATE103286T1 (de) Heteroring-substituierte diphosphonatverbindungen, arzneimittel und verfahren zur behandlung von abnormalen kalzium- und phosphatmetabolismen.
ATE109467T1 (de) Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropy idinderivaten als freie radikalfänger.
BR0005557A (pt) Compostos diidrofuro[3,4-b] quinolin-1-ona, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
DK491285D0 (da) 1,4-dihydropyridin-hydroxyaminer, deres fremstilling og anvendelse i laegemidler
DE69201184D1 (de) 5- Piperazinylalkyl-1,5-Benzothiazepinone verwendbar als Calciumantagonisten.
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
DK185984D0 (da) Disubstituerede polymethyleniminer,fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende dem
ATE239020T1 (de) Tricyclische verbindungen als ras-fpt inhibitoren
BR0007348A (pt) Uréias cìclicas ou lineares, processo para seupreparo e composições farmacêuticas contendo asmesmas
EA200000373A3 (ru) Новые соединения 1-аза-2-алкил-6-арилциклоалкана, способ их получения и содержащие их фармацевтические композиции
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
NO982363L (no) Fosfonsyrederivater med metallopeptidasehemmende aktivitet
DK99588A (da) 2-(aminoalkythio)methyl-1,4-dihydropyridin-forbindelser, en fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application